Rosuvastatin extended release (Lyndra)

瑞舒伐他汀缓释剂 (Lyndra)

Report date: 2024/05/31 09:49:15

Base Information

Drug NameRosuvastatin extended release (Lyndra)

Drug Alias NameLYN-047

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHMG-CoA reductase inhibitors

TargetsHMG-CoA reductase

Therapy Area/IndicationsDyslipidemias

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesLyndra Inc

China Registration ClassN/A

Active CompaniesLyndra Inc

Inactive CompaniesN/A

Active IndicationsDyslipidemias

Inactive IndicationsN/A

ATC CodeN/A